Teratogenic effects of HESA-A, a natural anticancer product from Iran, in mice

Human and Experimental Toxicology

Volumn 30, Issue 8, 2011, Pages 851-859

  Moallem, S A ^a,b,c   Ahmadi, A ^d   Moshafi, M ^e   Taghavi, M M ^f  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

dvelopmental toxicity; embryotoxicity; HESA A; mice

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; HERBACEOUS AGENT; HESA A; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; CLEFT PALATE; CONTROLLED STUDY; DRUG DOSE COMPARISON; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; FEMALE; FETUS; FETUS RESORPTION; FETUS WEIGHT; GASTROSCHISIS; GESTATIONAL AGE; HYDROCEPHALUS; IRAN; LIMB DEFORMITY; MICROPHTHALMIA; MOUSE; NONHUMAN; NOSE SEPTUM; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SKELETON MALFORMATION; SKIN CYST; SPINE MALFORMATION; SUBCUTANEOUS HEMORRHAGE; TERATOGENICITY; UTERUS WEIGHT; WEIGHT GAIN;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GESTATIONAL AGE; IRAN; LETHAL DOSE 50; MATERNAL EXPOSURE; MICE; MICE, INBRED BALB C; PLANT PREPARATIONS; PREGNANCY; TERATOGENS;

ANIMALIA; MUS;

EID: 79960749789     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110379521     Document Type: Article

References (24)

1. Sadeghi-Aliabadi H., Ahmadi A. Cytotoxicity and anti-tumor properties of a marine compound on cancer cells (HESA-A). Med J Islamic Acad Sci 2003 ; 13: 55-61.
2. Ahmadi A., Mohagheghi MA, and Sharif-Tabrizi A. Introducing the therapeutic effects of HESA-A on osteosarcoma induced in rabbits. Proceedings of the First National Congress on Cancer Research. Orumiah, Iran, 5-8 April 2001.
3. Ahmadi A., Mohagheghi MA, Fazeli MS, Nahavandian B., Bashardoost N., Musavi Jarahi A., et al. HESA-A: new treatment for breast cancer and choroidal metastasis. Med Sci Monit 2005 ; 11: CR300 - CR303.
4. Ahmadi A., Naderi G., and Asgari S. Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamideinduced hepatic damage in rabbits. Drugs Exp Clin Res 2005 ; 31: 1-6. (Pubitemid 40461565)
5. Balalimood M., et al. Evaluation of the toxicity of a marine anti-tumor agent (HESA-A) in mice and rats. J Birjand University of Medical Sciences 12: 5-12, 2005.
6. Fazly-Bazzaz BS Reports of Microbe Control Laboratory, School of Pharmacy, Mashahd University of Medical Sciences, 2004.
7. Shahabi A., Shirini R. HESA-A analysis. Isfahan Center for Research and Production of Fuels, Department of Miniature Reactor, 2001.
8. Organization for Economic Cooperation and Development (OECD) Codes of Good Laboratory Practice (GLP). May 1982, Doc C (81)30 (Final) Annex2.
9. Bernard BK, Hoberman AM A study of the developmental toxicity potential of pentachlorophenol in the rat. Int J Toxicol 2001 ; 20: 353-362. (Pubitemid 34056782)
10. Driscoll CD, Valentine R., Staples RE, Chromey NC, and Kennedy GL Jr. Developmental toxicity of diglyme by inhalation in the rat. Drug Chem Toxicol 1998 ; 21: 119-136. (Pubitemid 28228690)
11. Afshar M., Moallem SA, Mohamadpoor AH, Shiravi A., Jalalian SM, and Golalipour MJ Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice. Cutan Ocul Toxicol 2010 ; 29: 10-15.
12. Afshar M., Hassanzadeh-Taheri MM, Moallem SA, Tamizi A., and Golalipour MJ Teratogenic effects of gabapentin on the skeletal system of Balb/C mice fetuses. Neurosciences 2009 ; 14: 239-244.
13. Fascineli ML, Hunter ES 3rd, and De Grava Kempinas W. Fetotoxicity caused by the interaction between zinc and arsenic in mice. Teratog carcinog mutagen 2002 ; 22: 315-327. (Pubitemid 34977226)
14. Ilgaz C., Kocabiyik H., Erdogan D., Ozogul C., and Peker T. Application of the microwave beam radiation in double skeleton staining method. Gazi Med J 1997 ; 8: 151-155.
15. Kim BJ, Kim MS, Kim KB, Kim KW, Hong YM, Kim IK, et al. Sensitizing effects of cadmium on TNF-alpha-and TRAIL-mediated apoptosis of NIH3T3 cells with distinct expression patterns of p53. Carcinogenesis 2002 ; 23: 1411-1417. (Pubitemid 35021224)
16. Lutz J., Beck SL Caffeine decreases the occurance of cadmium-induced forelimb ectrodactyly in C57BL/6j mice. Teratology 2000 ; 62: 325-331.
17. Szakmary E., Ungváry G., Hudák A., Tátrai E., and Náray M., Morvai V. Effect of cobalt sulfate on prenatal development of mice, rats, and rabbits, and on early postnatal development of rats. J Toxicol Environ Health A 2001 ; 62: 367-386. (Pubitemid 32182301)
18. Wu MY, Chen SU, Chao KH, Chen CD, Yang YS, and Ho HN Mouse embryo toxicity of IL-6 in peritoneal fluids from women with or without endometriosis. Acta Obstet Gynecol Scand 2001 ; 80: 7-11.
19. Andrews JE, Ebron-Mccoy M., Schmid JE, and Svendsgaard D. Effects of combinations of methanol and formic acid on rat embryos in culture. Teratology 1998 ; 58: 54-61. (Pubitemid 28473070)
20. Cooper JR, Mattie DR Developmental toxicity of JP-8 jet fuel in the rat. J Appl Toxicol 1996 ; 16: 197-200. (Pubitemid 26228551)
21. Thrasher JD, Kilburn KH Embryo toxicity and teratogenicity of formaldehyde. Arch Environ Health 2001 ; 56: 300-311.
22. Leonard A., Gerber GB Mutagenicity, carcinogenicity and teratogenicity of aluminium. Mut Res 1988 ; 196: 247-257. (Pubitemid 19005225)
23. Matsumoto H., Iijima S., and Katsunuma H. Placental transfer of chromium chloride and its teratogenic potential in embryonic mice. J Toxicol Sci 1976 ; 1: 1-13. 24. Kimm-Brinson KL, Ramsdell JS The red tide toxin, brevetoxin, induces embryo toxicity and developmental abnormalities. Environ Health Perspect 2001 ; 109: 377-381. (Pubitemid 8313087)
24. Moallem SA, Ahmadi A., Nyapour M., Hosseini T., and Habibi G. Role of apoptosis in HESA-A teratogenicity in mice fetus. Drug Chem Toxicol 2009 ; 32: 186-190.